Alexander Biederstädt

9PUBLICATIONS
71CO-AUTHORS
Molecular targetsGene and molecular therapyReaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 04, 2025
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.

Hind Rafei, Rafet Basar, Sunil Acharya

|Sep 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

Bijender Kumar, Anand Singh, Rafet Basar

|Jun 20, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.

Sunil Acharya, Rafet Basar, May Daher

|Apr 11, 2024
Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center retrospective analysis.

Veronika Dill, Philipp Blüm, Anja Lindemann

|Sep 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.

Ye Li, Rafet Basar, Guohui Wang

|Jul 25, 2022
Natural killer cells in antitumour adoptive cell immunotherapy.

Tamara J Laskowski, Alexander Biederstädt, Katayoun Rezvani

Pageof 2

Frequent Collaborators

6 joint publications

Katayoun Rezvani

5 joint publications

Ye Li

5 joint publications

Ken Chen

3 joint publications

Mohsen Fathi